Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:27 AM UTC
| NCT Number | NCT06966453 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of March 2, 2026: Clinical trial NCT06966453 is currently recruiting participants. This clinical trial study for breast cancer is actively seeking new participants at 16 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06966453 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06966453 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.